Endocrine therapy predicts sexual distress in women cancer survivors

WASHINGTON — Endocrine therapy is one of the top predictors of sexual dysfunction in women cancer survivors, according to a study shown at the ACOG Annual Clinical & Scientific Meeting.“Perhaps the most surprising finding was what did not predict distress: age, menopausal status and chemotherapy were not independent predictors,” Claire F. Alcus, an MD candidate at University